| 000 | 01765 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250511192427.0 | ||
| 264 | 0 | _c19920512 | |
| 008 | 199205s 0 0 eng d | ||
| 022 | _a0890-9369 | ||
| 024 | 7 |
_a10.1101/gad.6.4.655 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKato, H | |
| 245 | 0 | 0 |
_aHIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. _h[electronic resource] |
| 260 |
_bGenes & development _cApr 1992 |
||
| 300 |
_a655-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aChloramphenicol O-Acetyltransferase _xgenetics |
| 650 | 0 | 4 |
_aDNA-Directed RNA Polymerases _xmetabolism |
| 650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
| 650 | 0 | 4 |
_aGene Products, tat _xmetabolism |
| 650 | 0 | 4 | _aHIV Long Terminal Repeat |
| 650 | 0 | 4 |
_aHIV-1 _xmetabolism |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aPeptide Elongation Factors _xmetabolism |
| 650 | 0 | 4 | _aPlasmids |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 | _aProtein Processing, Post-Translational |
| 650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
| 650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
| 650 | 0 | 4 | _aTranscription Factors, TFII |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _atat Gene Products, Human Immunodeficiency Virus |
| 700 | 1 | _aSumimoto, H | |
| 700 | 1 | _aPognonec, P | |
| 700 | 1 | _aChen, C H | |
| 700 | 1 | _aRosen, C A | |
| 700 | 1 | _aRoeder, R G | |
| 773 | 0 |
_tGenes & development _gvol. 6 _gno. 4 _gp. 655-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1101/gad.6.4.655 _zAvailable from publisher's website |
| 999 |
_c1566099 _d1566099 |
||